In vivo characterization and quantification of neurofibrillary tau PET radioligand 18F-MK-6240 in humans from Alzheimer’s disease dementia to young controls
Tobey J. Betthauser, Karly Alex Cody, Matthew D. Zammit, Dhanabalan Murali, Alexander K. Converse, Todd E. Barnhart, Charles K. Stone, Howard A. Rowley, Sterling C. Johnson, Bradley Christian
This paper evaluates the in vivo kinetics and quantification of the tau PET radioligand [18F]MK-6240 in humans across Alzheimer’s disease stages and controls.
Journal of Nuclear Medicine · May 18, 2018Peer-reviewedNeuroscience